$GNPX
Genprex Inc

2019 Q3 Form 10-Q Financial Statement

#000143774919022847 Filed on November 14, 2019

View on sec.gov

Income Statement

Concept 2019 Q3 2018 Q3 2018 Q2
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.910M $1.710M $5.920M
YoY Change 11.7% 159.09% 448.15%
% of Gross Profit
Research & Development $467.3K $489.7K $113.0K
YoY Change -4.56% 782.05% 7.61%
% of Gross Profit
Depreciation & Amortization $3.437K $1.713K $1.171K
YoY Change 100.64% 112.0%
% of Gross Profit
Operating Expenses $467.3K $489.7K $113.0K
YoY Change -4.56% 782.05% 7.61%
Operating Profit -$2.381M -$2.197M -$6.036M
YoY Change 8.35% 207.26% 411.02%
Interest Expense $30.58K
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$2.380M -$2.190M -$6.060M
YoY Change 8.68% 204.17% 413.56%
Income Tax
% Of Pretax Income
Net Earnings -$2.376M -$2.186M -$6.061M
YoY Change 8.67% 205.7% 413.15%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$150.3K -$149.2K -$448.6K
COMMON SHARES
Basic Shares Outstanding 15.84M 13.90M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q3 2018 Q3 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.550M $10.31M $12.00M
YoY Change -75.27% 2686.49% 2453.19%
Cash & Equivalents $2.548M $10.31M $12.00M
Short-Term Investments
Other Short-Term Assets $260.0K $370.0K $540.0K
YoY Change -29.73% 1133.33% 1700.0%
Inventory $800.0K
Prepaid Expenses
Receivables $0.00 $10.00K $0.00
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $3.609M $10.69M $12.54M
YoY Change -66.24% 2572.32% 2408.0%
LONG-TERM ASSETS
Property, Plant & Equipment $23.75K $15.99K $10.00K
YoY Change 48.51% 59.9% 0.0%
Goodwill
YoY Change
Intangibles $423.9K $323.1K
YoY Change
Long-Term Investments
YoY Change
Other Assets $435.7K $20.00K $336.6K
YoY Change 2078.28% -96.43% 52.98%
Total Long-Term Assets $459.4K $360.7K $350.9K
YoY Change 27.35% -58.54% -31.19%
TOTAL ASSETS
Total Short-Term Assets $3.609M $10.69M $12.54M
Total Long-Term Assets $459.4K $360.7K $350.9K
Total Assets $4.068M $11.05M $12.89M
YoY Change -63.18% 770.08% 1176.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $480.0K $570.0K $300.0K
YoY Change -15.79% 58.33% 76.47%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $60.00K $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $537.2K $570.0K $300.5K
YoY Change -5.75% 42.5% 43.11%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $537.2K $570.0K $300.5K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $540.0K $570.0K $300.0K
YoY Change -5.26% 42.5% 42.86%
SHAREHOLDERS EQUITY
Retained Earnings -$38.05M -$24.21M
YoY Change
Common Stock $15.84K $13.90K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.531M $10.48M $12.59M
YoY Change
Total Liabilities & Shareholders Equity $4.068M $11.05M $12.89M
YoY Change -63.18% 770.08% 1176.33%

Cashflow Statement

Concept 2019 Q3 2018 Q3 2018 Q2
OPERATING ACTIVITIES
Net Income -$2.376M -$2.186M -$6.061M
YoY Change 8.67% 205.7% 413.15%
Depreciation, Depletion And Amortization $3.437K $1.713K $1.171K
YoY Change 100.64% 112.0%
Cash From Operating Activities -$1.990M -$1.470M -$3.110M
YoY Change 35.37% 129.69% 364.18%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$10.00K -$20.00K
YoY Change -100.0% -50.0% 0.0%
Acquisitions
YoY Change
Other Investing Activities $50.00K
YoY Change
Cash From Investing Activities $40.00K -$10.00K -$20.00K
YoY Change -500.0% -50.0% 0.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -220.0K 15.11M
YoY Change -100.0% -139.29% 6469.57%
NET CHANGE
Cash From Operating Activities -1.990M -1.470M -3.110M
Cash From Investing Activities 40.00K -10.00K -20.00K
Cash From Financing Activities 0.000 -220.0K 15.11M
Net Change In Cash -1.950M -1.700M 11.98M
YoY Change 14.71% 1600.0% -2704.35%
FREE CASH FLOW
Cash From Operating Activities -$1.990M -$1.470M -$3.110M
Capital Expenditures $0.00 -$10.00K -$20.00K
Free Cash Flow -$1.990M -$1.460M -$3.090M
YoY Change 36.3% 135.48% 375.38%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Small Business
EntitySmallBusiness
true
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
12590373
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
10483934
CY2018Q1 gnpx Capital Stock Shares Authorized
CapitalStockSharesAuthorized
210000000
CY2018 gnpx Class Of Warrant Or Right Cancelled During Period
ClassOfWarrantOrRightCancelledDuringPeriod
15385
gnpx Class Of Warrant Or Right Cancelled During Period
ClassOfWarrantOrRightCancelledDuringPeriod
CY2018 gnpx Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
34615
gnpx Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
CY2018 gnpx Class Of Warrant Or Right Issued During Period Exercise Price
ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice
4.47
gnpx Class Of Warrant Or Right Issued During Period Exercise Price
ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice
gnpx Class Of Warrant Or Right Issued In Period
ClassOfWarrantOrRightIssuedInPeriod
0
CY2018 gnpx Class Of Warrant Or Right Issued In Period
ClassOfWarrantOrRightIssuedInPeriod
3166492
CY2019Q3 gnpx Investment Unit
InvestmentUnit
0
CY2018Q4 gnpx Investment Unit
InvestmentUnit
0
CY2018Q1 gnpx Issuance Of Stock For Cash Equity Impact
IssuanceOfStockForCashEquityImpact
CY2018Q2 gnpx Issuance Of Stock For Cash Equity Impact
IssuanceOfStockForCashEquityImpact
15389288
CY2018Q3 gnpx Issuance Of Stock For Cash Equity Impact
IssuanceOfStockForCashEquityImpact
CY2019Q1 gnpx Issuance Of Stock For Cash Equity Impact
IssuanceOfStockForCashEquityImpact
CY2019Q2 gnpx Issuance Of Stock For Cash Equity Impact
IssuanceOfStockForCashEquityImpact
CY2018Q2 gnpx Nonvoting To Voting Common Stock Conversion Ratio
NonvotingToVotingCommonStockConversionRatio
1
CY2019Q3 gnpx Number Of Allowed Patents
NumberOfAllowedPatents
1
CY2019Q3 gnpx Number Of Patents
NumberOfPatents
32
gnpx Operating Lease Rent Expense Per Month
OperatingLeaseRentExpensePerMonth
2050
gnpx Payments To Acquire Research And Development Assets
PaymentsToAcquireResearchAndDevelopmentAssets
801780
gnpx Payments To Acquire Research And Development Assets
PaymentsToAcquireResearchAndDevelopmentAssets
CY2017Q4 gnpx Percentage Of Outstanding Shares For Warrant To Purchase Shares Of Common Stock
PercentageOfOutstandingSharesForWarrantToPurchaseSharesOfCommonStock
0.03
CY2010 gnpx Proceeds From State Of Texas Emerging Technology Fund Award
ProceedsFromStateOfTexasEmergingTechnologyFundAward
2250000
CY2011 gnpx Proceeds From State Of Texas Emerging Technology Fund Award
ProceedsFromStateOfTexasEmergingTechnologyFundAward
2250000
CY2019Q3 gnpx Research And Development Assets Current
ResearchAndDevelopmentAssetsCurrent
801780
CY2018Q4 gnpx Research And Development Assets Current
ResearchAndDevelopmentAssetsCurrent
0
CY2010Q4 gnpx State Of Texas Emerging Technology Fund Award Amount
StateOfTexasEmergingTechnologyFundAwardAmount
4500000
CY2019Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
475048
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
295069
CY2019Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
41569745
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
38690586
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
46861
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3127563
CY2018Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
79647
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
330626
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1615896
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
540808
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2900000
CY2019Q3 us-gaap Assets
Assets
4068330
CY2018Q4 us-gaap Assets
Assets
9268956
CY2019Q3 us-gaap Assets Current
AssetsCurrent
3608928
CY2018Q4 us-gaap Assets Current
AssetsCurrent
8847066
CY2019Q3 us-gaap Cash
Cash
2548434
CY2018Q4 us-gaap Cash
Cash
8600918
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8600918
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
161251
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2548434
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10309704
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6052485
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10148453
CY2019Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2019Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
2366206
CY2018Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
8465768
CY2017Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
5.17
CY2018Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4.60
CY2019Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4.60
CY2017Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
748060
CY2018Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3864552
CY2019Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3864552
CY2019Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15842855
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15239148
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15842855
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15239148
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
15843
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
15240
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
2380763
CY2018Q3 us-gaap Costs And Expenses
CostsAndExpenses
2197278
us-gaap Costs And Expenses
CostsAndExpenses
8255419
us-gaap Costs And Expenses
CostsAndExpenses
8919997
CY2019Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
11732
CY2018Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
18085
us-gaap Depreciation
Depreciation
3831
us-gaap Depreciation
Depreciation
9486
CY2019Q3 us-gaap Depreciation
Depreciation
3437
CY2018Q3 us-gaap Depreciation
Depreciation
1713
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.15
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.15
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.53
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.67
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.21
CY2018Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
4500000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
CY2013Q4 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2500000
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1909982
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1705876
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6768506
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8261887
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2018 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Income Taxes Paid
IncomeTaxesPaid
us-gaap Income Taxes Paid
IncomeTaxesPaid
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
189907
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-63681
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-9297
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
313
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-759591
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
-6353
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
18085
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-34497
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
27862
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
346930
CY2019Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
423923
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
379451
CY2019Q3 us-gaap Interest Expense
InterestExpense
CY2018Q3 us-gaap Interest Expense
InterestExpense
us-gaap Interest Expense
InterestExpense
us-gaap Interest Expense
InterestExpense
37982
us-gaap Interest Paid Net
InterestPaidNet
us-gaap Interest Paid Net
InterestPaidNet
10645
CY2019Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
5051
CY2018Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
11192
us-gaap Investment Income Interest
InvestmentIncomeInterest
25620
us-gaap Investment Income Interest
InvestmentIncomeInterest
16682
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4068330
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9268956
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
537232
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
387821
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14972691
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-855132
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-39430
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5197353
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4784808
us-gaap Net Income Loss
NetIncomeLoss
-8229799
us-gaap Net Income Loss
NetIncomeLoss
-8941297
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-694001
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-6061213
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-2186086
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-2158846
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-3695240
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-2375712
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2380763
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2197278
us-gaap Operating Income Loss
OperatingIncomeLoss
-8255419
us-gaap Operating Income Loss
OperatingIncomeLoss
-8919997
CY2018Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
9600000
CY2019Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
435655
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
397536
CY2019Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
62184
CY2018Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
92752
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
44473
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
27413
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8879
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12017
CY2019Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2019Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
258714
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
236851
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
15174581
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23747
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24354
us-gaap Share Based Compensation
ShareBasedCompensation
2879762
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2019Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
CY2018Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
9297
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
201890
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
467344
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
489689
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1477427
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
654279
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-38054490
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-29824691
CY2019Q3 us-gaap Revenues
Revenues
CY2018Q3 us-gaap Revenues
Revenues
us-gaap Revenues
Revenues
us-gaap Revenues
Revenues
us-gaap Share Based Compensation
ShareBasedCompensation
3822076
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7687
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
127593
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
91813
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
91813
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2034525
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1461715
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4535681
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5905583
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2628749
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.31
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.31
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.94
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.21
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.60
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y233D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y302D
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
253707
CY2018 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
200009
CY2018 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
392432
CY2018 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
553303
CY2018Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
176650
CY2018Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
176650
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
8881135
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
7245311
CY2018Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
CY2019Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
192396
CY2019Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
159101
CY2019Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
40935
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
5325068
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
428574
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
-41915
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
3531098
CY2018Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
6.6841954
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-style: italic;">Use of Estimates</div></div></div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The preparation of our condensed financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</div></div></div></div></div></div></div>
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
15831822
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14675631
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
15598644
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
13323557

Files In Submission

Name View Source Status
0001437749-19-022847-index-headers.html Edgar Link pending
0001437749-19-022847-index.html Edgar Link pending
0001437749-19-022847.txt Edgar Link pending
0001437749-19-022847-xbrl.zip Edgar Link pending
ex_161212.htm Edgar Link pending
ex_161213.htm Edgar Link pending
ex_161214.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gnpx-20190930.xml Edgar Link completed
gnpx-20190930.xsd Edgar Link pending
gnpx-20190930_cal.xml Edgar Link unprocessable
gnpx-20190930_def.xml Edgar Link unprocessable
gnpx-20190930_lab.xml Edgar Link unprocessable
gnpx-20190930_pre.xml Edgar Link unprocessable
gnpx20190930_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending